Viewing Study NCT03356158


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-01-10 @ 2:12 PM
Study NCT ID: NCT03356158
Status: UNKNOWN
Last Update Posted: 2018-09-17
First Post: 2017-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-11-15
Start Date Type: ACTUAL
Primary Completion Date: 2018-10-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2018-11-30
Completion Date Type: ESTIMATED
First Submit Date: 2017-11-09
First Submit QC Date: None
Study First Post Date: 2017-11-29
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-09-13
Last Update Post Date: 2018-09-17
Last Update Post Date Type: ACTUAL